Clearly a major proportion of the profits for any pharmaceutical currently comes from the US, regardless of where those drugs were developed. If the global prof

Clearly a major proportion of the profits for any pharmaceutical currently comes from the US, regardless of where those drugs were developed. If the global profits for pharmaceuticals are curtailed because the US stops paying a premium it seems foolish to say that the profit motive wouldn't be impacted in regards to spending on pharmaceutical R&D.